Factors affecting immune responses to the influenza vaccine

References

• Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016; 65:1-54; PMID:27560619; https://doi.org/10.15585/mmwr.rr6505a1
   PubMed Web of Science ®Google Scholar
• Seidman JC, Richard SA, Viboud C, Miller MA. Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respir Viruses 2012; 6:52-62; PMID:21668661; https://doi.org/10.1111/j.1750-2659.2011.00268.x
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; https://doi.org/10.1016/S1473-3099(11)70295-X
   PubMed Web of Science ®Google Scholar
• Domínguez A, Godoy P, Torner N. The Effectiveness of Influenza Vaccination in Different Groups. Expert Rev Vaccines 2016; 15:751-64; PMID:26775669; https://doi.org/10.1586/14760584.2016.1142878
   PubMed Web of Science ®Google Scholar
• Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med 1999; 159:182-8; PMID:9927102; https://doi.org/10.1001/archinte.159.2.182
   PubMed Web of Science ®Google Scholar
• Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15:1114-22; PMID:9269055; https://doi.org/10.1016/S0264-410X(97)00003-0
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Kelly H. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clin Infect Dis 2013; 57:474-6; PMID:23619811; https://doi.org/10.1093/cid/cit255
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, et al. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27; PMID:24235265; https://doi.org/10.1093/cid/cit736
   PubMed Web of Science ®Google Scholar
• McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, Belongia EA. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 2014; 59:1375-85; PMID:25270645; https://doi.org/10.1093/cid/ciu680
   PubMed Web of Science ®Google Scholar
• Nauta JJ, Beyer WE, Osterhaus AD. On the relationship between mean antibody level, seroprotection and clinical protection from influenza. Biologicals 2009; 37:216-21; PMID:19268607; https://doi.org/10.1016/j.biologicals.2009.02.002
   PubMed Web of Science ®Google Scholar
• Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol 2010; 10:18; PMID:20210985; https://doi.org/10.1186/1471-2288-10-18
   PubMed Web of Science ®Google Scholar
• Thompson MG, Naleway A, Fry AM, Ball S, Spencer AM, Reynolds S, Bozeman S, Levine M, Katz JM, Gaglani M. Effects of repeated annual inactivated influenza vaccination among healthcare personnel on serum hemagglutinin inhibition antibody response to A/Perth/16/2009 (H3N2)-like virus during 2010–11. Vaccine 2016; 34:981-8; PMID:26813801; https://doi.org/10.1016/j.vaccine.2015.10.119
   PubMed Web of Science ®Google Scholar
• Kunzel W, Glathe H, Engelmann H, Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996; 14:1108-10; PMID:8911005; https://doi.org/10.1016/0264-410X(96)00061-8
   PubMed Web of Science ®Google Scholar
• De Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp GG, Knook DL. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 1999; 179:31-6; PMID:9841819; https://doi.org/10.1086/314540
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C, Kane KP, Bleackley RC. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176:6333-9; PMID:16670345; https://doi.org/10.4049/jimmunol.176.10.6333
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C, Kane KP, Bleackley RC. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009; 27:2418-25; PMID:19368783; https://doi.org/10.1016/j.vaccine.2009.01.136
   PubMed Web of Science ®Google Scholar
• Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, Bouvier N, Kemble G, Greenberg HB, Lewis DB, Arvin AM, Dekker CL. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr Infect Dis J 2007; 26:107-15; PMID:17259871; https://doi.org/10.1097/01.inf.0000253251.03785.9b
   PubMed Web of Science ®Google Scholar
• Reber AJ, Kim JH, Biber R, Talbot HK, Coleman AL, Chirkova T, Gross FL, Steward-Clark E, Cao W, Jefferson S, et al. Preexisting immunity, more than aging, influences influenza vaccine responses. Open Forum Infect Dis 2015; 2(2):ofv052; PMID:26380344; https://doi.org/10.1093/ofid/ofv052
   PubMed Web of Science ®Google Scholar
• Andrews SF, Kaur K, Pauli NT, Huang M, Huang Y, Wilson PC. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response. J Virol 2015; 89:3308-17; PMID:25589639; https://doi.org/10.1128/JVI.02871-14
   PubMed Web of Science ®Google Scholar
• Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, et al. Antibody landscapes after influenza virus infection or vaccination. Science 2014; 346:996-1000; PMID:25414313; https://doi.org/10.1126/science.1256427
   PubMed Web of Science ®Google Scholar
• Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Mapping the antigenic and genetic evolution of influenza virus. Science 2004; 305:371-6; PMID:15218094; https://doi.org/10.1126/science.1097211
   PubMed Web of Science ®Google Scholar
• Lee J, Boutz DR, Chromikova V, Joyce MG, Vollmers C, Leung K, Horton AP, DeKosky BJ, Lee CH, Lavinder JJ, et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat Med 2016; 22:1456-64; PMID:27820605; https://doi.org/10.1038/nm.4224
   PubMed Web of Science ®Google Scholar
• Pleguezuelos O, Robinson S, Fernandez A, Stoloff GA, Caparrós-Wanderley W. Meta-analysis and potential role of preexisting heterosubtypic cellular immunity based on variations in disease severity outcomes for influenza live viral challenges in humans. Clin Vaccine Immunol 2015; 22:949-56; PMID:26084515; https://doi.org/10.1128/CVI.00101-15
   PubMed Web of Science ®Google Scholar
• Trieu MC, Zhou F, Lartey S, Jul-Larsen Å, Mjaaland S, Sridhar S, Cox RJ. Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination. J Infect Dis 2017; 215:740-49; PMID:28007925
   PubMed Web of Science ®Google Scholar
• Jegaskanda S, Luke C, Hickman HD, Sangster MY, Wieland-Alter WF, McBride JM, Yewdell JW, Wright PF, Treanor J, Rosenberger CM, Subbarao K. Generation and protective ability of influenza virus-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental challenge. J Infect Dis 2016; 214:945-52; PMID:27354365; https://doi.org/10.1093/infdis/jiw262
   PubMed Web of Science ®Google Scholar
• de Vries RD, Nieuwkoop NJ, Pronk M, de Bruin E, Leroux-Roels G, Huijskens EG, van Binnendijk RS, Krammer F, Koopmans MP, Rimmelzwaan GF. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection. Vaccine 2017; 35:238-47; PMID:27914742; https://doi.org/10.1016/j.vaccine.2016.11.082
   PubMed Web of Science ®Google Scholar
• Gostic KM, Ambrose M, Worobey M, Lloyd-Smith JO. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science 2016; 354:722-26; PMID:27846599; https://doi.org/10.1126/science.aag1322
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69; PMID:16213065; https://doi.org/10.1016/j.vaccine.2005.08.105
   PubMed Web of Science ®Google Scholar
• Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, Nishtala M, Wrammert J, Smith K, James JA, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 2011; 121:3109-19; PMID:21785218; https://doi.org/10.1172/JCI57834
   PubMed Web of Science ®Google Scholar
• Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272:1661-5; PMID:7966893; https://doi.org/10.1001/jama.1994.03520210045030
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366:1165-74; PMID:16198765; https://doi.org/10.1016/S0140-6736(05)67339-4
   PubMed Web of Science ®Google Scholar
• Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 2013; 31:6030-3; PMID:24095882; https://doi.org/10.1016/j.vaccine.2013.09.063
   PubMed Web of Science ®Google Scholar
• Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S. Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis 2012; 3:68-90; PMID:22500272
   PubMed Web of Science ®Google Scholar
• Pinti M, Appay V, Campisi J, Frasca D, Fülöp T, Sauce D, Larbi A, Weinberger B, Cossarizza A. Aging of the immune system: Focus on inflammation and vaccination. Eur J Immunol 2016; 46:2286-301; PMID:27595500; https://doi.org/10.1002/eji.201546178
   PubMed Web of Science ®Google Scholar
• Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010; 184:2518-27; PMID:20100933; https://doi.org/10.4049/jimmunol.0901022
   PubMed Web of Science ®Google Scholar
• Mysliwska J, Trzonkowski P, Szmit E, Brydak LB, Machala M, Mysliwski A. Immunomodulating effect of influenza vaccination in the elderly differing in health status. Exp Gerontol 2004; 39:1447-58; PMID:15501014; https://doi.org/10.1016/j.exger.2004.08.005
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, Griffin GE, Taylor GP, Tough DF, Beverley PC, et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 2007; 121:258-65; PMID:17346281; https://doi.org/10.1111/j.1365-2567.2007.02573.x
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75(24):12182-87; PMID:11711609; https://doi.org/10.1128/JVI.75.24.12182-12187.2001
   PubMed Web of Science ®Google Scholar
• Saurwein-Teissl M, Lung TL, Marx F, Gschösser C, Asch E, Blasko I, Parson W, Böck G, Schönitzer D, Trannoy E, Grubeck-Loebenstein B. Lack of antibody production following immunization in old age: association with CD8(+)CD28(−) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168:5893-9; PMID:12023394; https://doi.org/10.4049/jimmunol.168.11.5893
   PubMed Web of Science ®Google Scholar
• Haynes L, Eaton SM. The effect of age on the cognate function of CD4+ T cells. The frequencies of CD8+ CD28− T cells can be used to predict influenza vaccine response in elderly people. Immunol Rev 2005; 205:220-8; PMID:15882356; https://doi.org/10.1111/j.0105-2896.2005.00255.x
   PubMed Web of Science ®Google Scholar
• Allman D, Miller JP. B cell development and receptor diversity during aging. Curr Opin Immunol 2005; 17:463-7; PMID:16054808; https://doi.org/10.1016/j.coi.2005.07.002
   PubMed Web of Science ®Google Scholar
• Frasca D, Riley RL, Blomberg BB. Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin Immunol 2005; 17:378-84; PMID:15996480; https://doi.org/10.1016/j.smim.2005.05.005
   PubMed Web of Science ®Google Scholar
• Najarro K, Nguyen H, Chen G, Xu M, Alcorta S, Yao X, Zukley L, Metter EJ, Truong T, Lin Y, et al. Telomere length as an indicator of the robustness of B- and T-cell response to influenza in older adults. J Infect Dis 2015; 212:1261-9; PMID:25828247; https://doi.org/10.1093/infdis/jiv202
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908:244-54; PMID:10911963; https://doi.org/10.1111/j.1749-6632.2000.tb06651.x
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Zhou X, Talbot HK, Soethout E, Bleackley RC, Granville DJ, Pawelec G. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012; 30:2060-7; PMID:22289511; https://doi.org/10.1016/j.vaccine.2012.01.015
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Myśliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak LB, Machała M, Myśliwski A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination–an impact of immunosenescence. Vaccine 2003; 21:3826-36; PMID:12922116; https://doi.org/10.1016/S0264-410X(03)00309-8
   PubMed Web of Science ®Google Scholar
• Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu YL, Cičin-Šain L, Dechanet-Merville J, Derhovanessian E, Ferrando-Martinez S, et al. New advances in CMV and immunosenescence. Exp Gerontol 2014; 55:54-62; PMID:24703889; https://doi.org/10.1016/j.exger.2014.03.020
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 2015; 33(12):1433-9; PMID:25659271; https://doi.org/10.1016/j.vaccine.2015.01.071
   PubMed Web of Science ®Google Scholar
• Derhovanessian E, Theeten H, Hähnel K, Van Damme P, Cools N, Pawelec G. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 2013; 31:685-90; PMID:23196209; https://doi.org/10.1016/j.vaccine.2012.11.041
   PubMed Web of Science ®Google Scholar
• Obermoser G, Presnell S, Domico K, Xu H, Wang Y, Anguiano E, Thompson-Snipes L, Ranganathan R, Zeitner B, Bjork A, et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 2013; 38:831-44; PMID:23601689; https://doi.org/10.1016/j.immuni.2012.12.008
   PubMed Web of Science ®Google Scholar
• Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, Wang E, Olnes MJ, Narayanan M, Golding H, et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 2014; 157:499-513; PMID:24725414; https://doi.org/10.1016/j.cell.2014.03.031
   PubMed Web of Science ®Google Scholar
• Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 2014; 15:195-204; PMID:24336226; https://doi.org/10.1038/ni.2789
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Wrammert J, Lee EK, Racioppi L, Kunze SM, Haining WN, Means AR, Kasturi N, Khan N, Li GM, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12:786-95; PMID:21743478; https://doi.org/10.1038/ni.2067
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, Rouphael N, Frasca D, Gersten M, Mehta AK, Gaujoux R, et al. Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures. Immunity 2015; 43:1186-98; PMID:26682988; https://doi.org/10.1016/j.immuni.2015.11.012
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Oberg AL, Kennedy RB, Zimmermann MT, Haralambieva IH, Goergen KM, Grill DE, Poland GA. Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals. Heliyon 2016; 2:e00098; PMID:27441275; https://doi.org/10.1016/j.heliyon.2016.e00098
   PubMed Web of Science ®Google Scholar
• Poland GA, Kennedy RB, Ovsyannikova IG. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? PLoS Pathog 2011; 7(12):e1002344
   PubMed Web of Science ®Google Scholar
• Haralambieva IH, Painter SD, Kennedy RB, Ovsyannikova IG, Lambert ND, Goergen KM, Oberg AL, Poland GA. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects. PLoS One 2015; 10(3):e0122282; PMID:25816015; https://doi.org/10.1371/journal.pone.0122282
   PubMed Web of Science ®Google Scholar
• Zimmermann MT, Oberg AL, Grill DE, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Poland GA. System-wide associations between DNA-methylation, gene expression, and humoral immune response to influenza vaccination. PLoS One 2016; 11(3):e0152034; PMID:27031986; https://doi.org/10.1371/journal.pone.0152034
   PubMed Web of Science ®Google Scholar
• Kennedy RB, Ovsyannikova IG, Haralambieva IH, Oberg AL, Zimmermann MT, Grill DE, Poland GA. Immunosenescence-related transcriptomic and immunologic changes in older individuals following influenza vaccination. Front Immunol 2016; 7:450; PMID:27853459; https://doi.org/10.3389/fimmu.2016.00450
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 1996; 93:3043-7; PMID:8610165; https://doi.org/10.1073/pnas.93.7.3043
   PubMed Web of Science ®Google Scholar
• Remarque EJ, Cools HJ, Boere TJ, van der Klis RJ, Masurel N, Ligthart GJ. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. BMJ 1996; 312:1015; PMID:8616350; https://doi.org/10.1136/bmj.312.7037.1015
   PubMed Web of Science ®Google Scholar
• Vedhara K, Cox NK, Wilcock GK, Perks P, Hunt M, Anderson S, Lightman SL, Shanks NM. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999; 353:627-31; PMID:10030328; https://doi.org/10.1016/S0140-6736(98)06098-X
   PubMed Web of Science ®Google Scholar
• Potter JM, O'Donnell B, Carman WF, Roberts MA, Stott DJ. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Aging 1999; 28:141-5; https://doi.org/10.1093/ageing/28.2.141
   PubMed Web of Science ®Google Scholar
• Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200:172-80; PMID:19508159; https://doi.org/10.1086/599790
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198:650-8; PMID:18652550; https://doi.org/10.1086/590434
   PubMed Web of Science ®Google Scholar
• Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine 2001; 19:2673-80; PMID:11257408; https://doi.org/10.1016/S0264-410X(00)00499-0
   PubMed Web of Science ®Google Scholar
• Chen WH, Cross AS, Edelman R, Sztein MB, Blackwelder WC, Pasetti MF. Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine 2011; 29(16):2865-73; PMID:21352939; https://doi.org/10.1016/j.vaccine.2011.02.017
   PubMed Web of Science ®Google Scholar
• Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, Lonetto MA, Maecker HT, Kovarik J, Carson S, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med 2014; 6(268):268ra179; PMID:25540326; https://doi.org/10.1126/scitranslmed.3009892
   PubMed Web of Science ®Google Scholar
• Keating R, Hertz T, Wehenkel M, Harris TL, Edwards BA, McClaren JL, Brown SA, Surman S, Wilson ZS, Bradley P, et al. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat Immunol 2013; 14:1266-76; PMID:24141387; https://doi.org/10.1038/ni.2741
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 2007; 82:653-64; PMID:17971814; https://doi.org/10.1038/sj.clpt.6100415
   PubMed Web of Science ®Google Scholar
• Posteraro B, Pastorino R, Di Giannantonio P, Ianuale C, Amore R, Ricciardi W, Boccia S. The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses. Vaccine 2014; 32:1661-9; PMID:24513009; https://doi.org/10.1016/j.vaccine.2014.01.057
   PubMed Web of Science ®Google Scholar
• Linnik JE, Egli A. Impact of host genetic polymorphisms on vaccine induced antibody response. Hum Vaccin Immunother 2016; 12:907-15; PMID:26809773; https://doi.org/10.1080/21645515.2015.1119345
   PubMed Web of Science ®Google Scholar
• Gelder CM, Lambkin R, Hart KW, Fleming D, Williams OM, Bunce M, Welsh KI, Marshall SE, Oxford J. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 2002; 185:114-7; PMID:11756990; https://doi.org/10.1086/338014
   PubMed Web of Science ®Google Scholar
• Moss AJ, Gaughran FP, Karasu A, Gilbert AS, Mann AJ, Gelder CM, Oxford JS, Stephens HA, Lambkin-Williams R. Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination. PLoS One 2013; 8(8):e71376; PMID:23951151; https://doi.org/10.1371/journal.pone.0071376
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM. Immunogenetics of seasonal influenza vaccine response. Vaccine 2008; 26(Suppl 4):D35-40; PMID:19230157; https://doi.org/10.1016/j.vaccine.2008.07.065
   PubMed Web of Science ®Google Scholar
• Egli A, Santer DM, O'Shea D, Barakat K, Syedbasha M, Vollmer M, Baluch A, Bhat R, Groenendyk J, Joyce MA, et al. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog 2014; 10(12):e1004556; PMID:25503988; https://doi.org/10.1371/journal.ppat.1004556
   PubMed Web of Science ®Google Scholar
• Franco LM, Bucasas KL, Wells JM, Niño D, Wang X, Zapata GE, Arden N, Renwick A, Yu P, Quarles JM, et al. Integrative genomic analysis of the human immune response to influenza vaccination. Elife 2013; 2:e00299; PMID:23878721; https://doi.org/10.7554/eLife.00299
   PubMed Web of Science ®Google Scholar
• Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 2010; 10:338-49; PMID:; PMID:20417416; https://doi.org/10.1016/S1473-3099(10)70049-9
   PubMed Web of Science ®Google Scholar
• Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell 2015; 14:309-21; PMID:25720438; https://doi.org/10.1111/acel.12326
   PubMed Web of Science ®Google Scholar
• Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168:2405-14; PMID:19064822; https://doi.org/10.1001/archinternmed.2008.513
   PubMed Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol 2016; 16:626-38; PMID:27546235; https://doi.org/10.1038/nri.2016.90
   PubMed Web of Science ®Google Scholar
• Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiébaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A 2014; 111:869-74; PMID:24367114; https://doi.org/10.1073/pnas.1321060111
   PubMed Web of Science ®Google Scholar
• Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008; 8:737-44; PMID:18728636; https://doi.org/10.1038/nri2394
   PubMed Web of Science ®Google Scholar
• Ghorai A, Ghosh U. miRNA gene counts in chromosomes vary widely in a species and biogenesis of miRNA largely depends on transcription or post-transcriptional processing of coding genes. Front Genet 2014; 5:100; PMID:24808907; https://doi.org/10.3389/fgene.2014.00100
   PubMed Web of Science ®Google Scholar
• Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, Belay B, Jain S, Cox C, Kamimoto L, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010; 5(3):e9694; PMID:20300571; https://doi.org/10.1371/journal.pone.0009694
   PubMed Web of Science ®Google Scholar
• Yang L, Chan KP, Lee RS, Chan WM, Lai HK, Thach TQ, Chan KH, Lam TH, Peiris JS, Wong CM. Obesity and influenza associated mortality: evidence from an elderly cohort in Hong Kong. Prev Med 2013; 56:118-23; PMID:23219760; https://doi.org/10.1016/j.ypmed.2012.11.017
   PubMed Web of Science ®Google Scholar
• Azziz-Baumgartner E, Cabrera AM, Chang L, Calli R, Kusznierz G, Baez C, Yedlin P, Zamora AM, Cuezzo R, Sarrouf EB, et al. Mortality, severe acute respiratory infection, and influenza-like ill-ness associated with influenza A(H1N1)pdm09 in Argentina, 2009. PLoS One 2012; 7(10):e47540; https://doi.org/10.1371/journal.pone.0047540
   PubMed Web of Science ®Google Scholar
• Paich HA, Sheridan PA, Handy J, Karlsson EA, Schultz-Cherry S, Hudgens MG, Noah TL, Weir SS, Beck MA. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) 2013; 21:2377-86; PMID:23512822; https://doi.org/10.1002/oby.20383
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim JK, Kim DJ, Nam JH, Shim SM, Choi YK, Lee CH, Poo H. Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J Infect Dis 2012; 205:244-51; https://doi.org/10.1093/infdis/jir731
   PubMed Web of Science ®Google Scholar
• Park HL, Shim SH, Lee EY, Cho W, Park S, Jeon HJ, Ahn SY, Kim H, Nam JH. Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vaccin Immunother 2014; 10:1181-6; PMID:24614530; https://doi.org/10.4161/hv.28332
   PubMed Web of Science ®Google Scholar
• Karlsson EA, Hertz T, Johnson C, Mehle A, Krammer F, Schultz-Cherry S. Obesity outweighs protection conferred by adjuvanted influenza vaccination. MBio 2016; 7(4):pii: e01144-16; https://doi.org/10.1128/mBio.01144-16
   Web of Science ®Google Scholar
• Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, Holland LA, Weir S, Noah TL, Beck MA. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012; 36:1072-7; PMID:22024641; https://doi.org/10.1038/ijo.2011.208
   PubMed Web of Science ®Google Scholar
• Frasca D, Ferracci F, Diaz A, Romero M, Lechner S, Blomberg BB. Obesity decreases B cell responses in young and elderly individuals. Obesity (Silver Spring) 2016; 24:615-25; PMID:26857091; https://doi.org/10.1002/oby.21383
   PubMed Web of Science ®Google Scholar
• Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, Shay DK, Belongia EA, Griffin MR. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine 2012; 30:3937-43; PMID:22484350; https://doi.org/10.1016/j.vaccine.2012.03.071
   PubMed Web of Science ®Google Scholar
• Callahan ST, Wolff M, Hill HR, Edwards KM, NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis 2014; 210:1270-4; PMID:24795475; https://doi.org/10.1093/infdis/jiu245
   PubMed Web of Science ®Google Scholar
• Esposito S, Giavoli C, Trombetta C, Bianchini S, Montinaro V, Spada A, Montomoli E, Principi N. Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children. Vaccine 2016; 34:56-60; PMID:26608327; https://doi.org/10.1016/j.vaccine.2015.11.019
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 2002; 29:2555-7; PMID:12465151
   PubMed Web of Science ®Google Scholar
• Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology (Oxford) 2009; 48:1294-9; PMID:19692457; https://doi.org/10.1093/rheumatology/kep200
   PubMed Web of Science ®Google Scholar
• Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 2007; 6:300-5
   PubMed Web of Science ®Google Scholar
• Kaur K, Zheng NY, Smith K, Huang M, Li L, Pauli NT, Henry Dunand CJ, Lee JH, Morrissey M, Wu Y, et al. High affinity antibodies against influenza characterize the plasmablast response in SLE patients after vaccination. PLoS One 2015; 10(5):e0125618; PMID:25951191; https://doi.org/10.1371/journal.pone.0125618
   PubMed Web of Science ®Google Scholar
• Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006; 24:3217-23; PMID:16466833; https://doi.org/10.1016/j.vaccine.2006.01.028
   PubMed Web of Science ®Google Scholar
• Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, Facchini M, Nisini R, Biselli R, Ferlito C, Podestà E, et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol 2010; 134:113-20; PMID:19846344; https://doi.org/10.1016/j.clim.2009.09.014
   PubMed Web of Science ®Google Scholar
• Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, et al. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 2008; 67:937-41; PMID:17981914; https://doi.org/10.1136/ard.2007.077461
   PubMed Web of Science ®Google Scholar
• Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine 2011; 29:444-50; PMID:21078406; https://doi.org/10.1016/j.vaccine.2010.10.081
   PubMed Web of Science ®Google Scholar
• Liao Z, Tang H, Xu X, Liang Y, Xiong Y, Ni J. Immunogenicity and safety of influenza vaccination in systemic lupus erythematosus patients compared with healthy controls: A meta-analysis. PLoS One 2016; 11(2):e0147856; PMID:26845680; https://doi.org/10.1371/journal.pone.0147856
   PubMed Web of Science ®Google Scholar
• Agency EM. Note for guidance on harmonization of requirements for influenza vaccine. London: European Medicine Agency; 1996
   Google Scholar
• Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010; 28:2481-90; PMID:20385981; https://doi.org/10.1200/JCO.2009.26.6908
   PubMed Web of Science ®Google Scholar
• Ortbals DW, Liebhaber H, Presant CA, Van Amburg AL III, Lee JY. Influenza immunization of adult patients with malignant diseases. Ann Intern Med 1977; 87:552-7; PMID:921082; https://doi.org/10.7326/0003-4819-87-5-552
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:e44-100; https://doi.org/10.1093/cid/cit684
   PubMed Web of Science ®Google Scholar
• Keam B, Kim MK, Choi Y, Choi SJ, Choe PG, Lee KH, Kim TM, Kim TY, Oh DY, Kim DW, et al. Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles. Cancer 2016; 123(5):841-8. [ Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Ceravolo A, Orsi A, Parodi V, Ansaldi F. Influenza vaccination in HIV-positive subjects: latest evidence and future perspective. J Prev Med Hyg 2013; 54:1-10; PMID:24396998
   PubMedGoogle Scholar
• Tasker SA, Treanor JJ, Paxton WB, Wallace MR. Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131:430-3; PMID:10498559; https://doi.org/10.7326/0003-4819-131-6-199909210-00006
   PubMed Web of Science ®Google Scholar
• Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999; 28:541-7; PMID:10194075; https://doi.org/10.1086/515170
   PubMed Web of Science ®Google Scholar
• Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 2000; 18:3040-9; PMID:10825608; https://doi.org/10.1016/S0264-410X(00)00079-7
   PubMed Web of Science ®Google Scholar
• Cagigi A, Nilsson A, Pensieroso S, Chiodi F. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 2010; 10:499-503; PMID:20610332; https://doi.org/10.1016/S1473-3099(10)70117-1
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Zangari P, Cotugno N, Manno EC, Brolatti N, Castrucci MR, Donatelli I, Rossi P, Palma P, Cagigi A. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza. Vaccine 2014; 32:657-63; PMID:24333344; https://doi.org/10.1016/j.vaccine.2013.12.008
   PubMed Web of Science ®Google Scholar
• Wheatley AK, Kristensen AB, Lay WN, Kent SJ. HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation. Sci Rep 2016; 6:26478; PMID:27220898; https://doi.org/10.1038/srep26478
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Cagigi A, Santilli V, Zotta F, di Martino A, Castrucci MR, Donatelli I, Poggi E, Piazza A, Campana A, et al. B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012–2013 flu vaccination experience. Transplantation 2014; 98:259-66; PMID:24911036; https://doi.org/10.1097/TP.0000000000000209
   PubMed Web of Science ®Google Scholar
• Nath KD, Burel JG, Shankar V, Pritchard AL, Towers M, Looke D, Davies JM, Upham JW. Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014; 9:51-6; PMID:24399872
   PubMed Web of Science ®Google Scholar
• Valentini D, Marcellini V, Bianchi S, Villani A, Facchini M, atelli I, Castrucci MR, Marasco E, Farroni C, Carsetti R. Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings. Vaccine 2015; 33:6689-96; PMID:26518399; https://doi.org/10.1016/j.vaccine.2015.10.083
   PubMed Web of Science ®Google Scholar
• Boyd SD, Jackson KJ. Predicting vaccine responsiveness. Cell Host Microbe 2015; 17:301-7; PMID:25766292; https://doi.org/10.1016/j.chom.2015.02.015
   PubMed Web of Science ®Google Scholar
• Hagan T, Nakaya HI, Subramaniam S, Pulendran B. Systems vaccinology: Enabling rational vaccine design with systems biological approaches. Vaccine 2015; 33:5294-301; PMID:25858860; https://doi.org/10.1016/j.vaccine.2015.03.072
   PubMed Web of Science ®Google Scholar
• Killingley B, Enstone JE, Greatorex J, Gilbert AS, Lambkin-Williams R, Cauchemez S, Katz JM, Booy R, Hayward A, Oxford J, et al. Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. J Infect Dis 2012; 205:35-43; PMID:22131338; https://doi.org/10.1093/infdis/jir701
   PubMed Web of Science ®Google Scholar
• Memoli MJ, Czajkowski L, Reed S, Athota R, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, et al. Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study. Clin Infect Dis 2015; 60(5):693-702; https://doi.org/10.1093/cid/ciu924
   PubMed Web of Science ®Google Scholar
• Krammer F, Palese P. Advances in the development of influenza virus vaccines. Nat Rev Drug Discov 2015; 14:167-82; PMID:25722244; https://doi.org/10.1038/nrd4529
   PubMed Web of Science ®Google Scholar
• de Vries RD, Altenburg AF, Rimmelzwaan GF. Universal influenza vaccines: a realistic option? Clin Microbiol Infect 2016; 22(Suppl 5):S120-S124
   PubMedGoogle Scholar